hg_159724.1

Basic information about the TSS

---

TSS ID: hg_159724.1 Species: human Chr: chr17		Start: 17042506 End: 17042515 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000577514.5 Distance: 30 GeneID: 23164 HGNC/MGI_ID: HGNC:30321 UniProt_ID: J3KSK7

Gene_name: myosin phosphatase Rho interacting protein Gene_symbol: MPRIP Gene_synonyms: M-RIP RHOIP3 p116Rip Gene_source: HGNC:30321

TATA-Box annotation

---

Distance to TSS:	54
Nearest PromoterID:	NM_001364716
Entrez ID:	23164
Nearest Unigene:	Hs.462341
Nearest Refseq:	NM_015134
Nearest Ensembl:	ENSG00000133030
Gene Name:	myosin phosphatase Rho interacting protein
Gene Alias:	M-RIP|MRIP|RHOIP3|RIP3|p116Rip
Gene Description:	myosin phosphatase Rho interacting protein
Gene Type:	protein-coding
CpG%:	0.19
GC%:	0.840796
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MPRIP p2@MPRIP p3@MPRIP p4@MPRIP
Sample		p1@MPRIP	p2@MPRIP	p3@MPRIP	p4@MPRIP
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	27.66	10.91	1.56	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	35.20	14.36	1.21	1.01
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	34.92	12.15	1.74	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	33.47	11.23	1.04	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	33.52	13.50	1.57	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	30.04	13.18	0.97	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	37.04	16.12	2.61	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	39.97	12.11	2.66	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	41.67	11.97	1.71	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	47.53	19.13	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	39.21	16.98	2.02	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	54.48	14.64	3.25	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	22.24	23.53	1.13	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	16.84	21.80	0.75	1.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	16.69	22.39	1.10	3.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	19.87	18.11	1.26	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	13.98	17.25	0.44	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	13.92	14.76	1.69	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	14.93	10.13	1.07	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	22.11	27.68	1.05	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	15.77	20.98	1.07	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	23.48	23.99	1.04	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	17.84	23.52	0.78	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	21.35	18.93	0.73	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	21.16	21.93	1.03	2.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	23.74	23.42	0.32	3.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	16.48	17.58	0.55	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	29.70	29.23	1.18	3.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	22.29	22.61	0.16	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	28.41	26.06	0.54	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	21.35	19.68	0.63	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	25.99	20.91	0.20	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	23.64	20.68	1.06	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	16.99	15.83	0.49	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	27.86	28.80	0.37	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	32.19	25.49	0.96	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	31.47	28.20	0.82	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	25.39	21.16	0.81	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	24.04	22.15	0.54	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	26.89	25.45	1.44	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	24.70	22.35	0.24	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	20.79	20.79	0.73	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	28.89	31.00	1.27	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	34.62	31.82	0.87	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	27.91	25.30	0.80	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	28.85	26.06	0.70	2.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	35.03	30.47	0.24	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	29.21	25.04	1.19	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	32.32	31.60	1.44	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	27.09	24.67	0.40	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	29.10	22.54	1.23	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	34.02	30.91	0.22	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	18.45	24.13	0.00	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	22.20	23.20	0.99	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	6.71	13.42	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	19.75	16.53	0.46	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	26.25	21.72	0.97	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	22.48	16.70	0.00	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	31.12	23.57	1.26	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	19.74	20.45	2.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	25.24	21.31	0.56	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	16.72	20.70	1.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	36.36	24.46	0.34	3.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	27.29	23.07	0.97	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	25.56	18.10	0.71	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	21.45	13.16	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	21.82	15.37	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	22.52	19.23	0.94	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.19	13.91	0.66	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	15.16	16.40	0.00	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	18.65	14.06	0.31	0.92
Adipocyte - breast, donor1	11376-118A8	25.97	18.69	0.79	1.90
Adipocyte - breast, donor2	11327-117E4	21.82	17.33	1.12	0.32
Adipocyte - omental, donor1	11473-119C6	23.28	22.90	0.64	1.65
Adipocyte - omental, donor2	11474-119C7	18.69	34.38	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	23.11	29.47	0.33	1.34
Adipocyte - perirenal, donor1	11476-119C9	9.57	19.14	0.64	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	3.30	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	19.42	13.10	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	12.16	14.08	0.00	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	30.70	16.82	0.39	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	20.59	9.52	0.00	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	18.12	8.36	0.00	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	30.57	12.93	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	14.64	13.67	0.80	1.05
Adipocyte differentiation, day08, donor2	13023-139D8	16.46	6.13	0.00	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	15.46	7.46	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	13.91	10.02	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	12.48	9.57	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	12.06	6.53	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	11.45	9.82	0.33	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	10.96	8.83	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	41.55	38.01	0.44	9.28
Alveolar Epithelial Cells, donor2	11590-120G6	41.24	60.96	1.43	4.66
Alveolar Epithelial Cells, donor3	11671-122G6	23.96	27.55	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	37.96	37.96	0.54	2.88
Amniotic Epithelial Cells, donor2	11613-122A2	36.82	38.49	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	31.23	36.16	0.41	3.08
Anulus Pulposus Cell, donor1	11248-116E6	17.85	14.30	0.92	0.34
Anulus Pulposus Cell, donor2	11463-119B5	14.69	20.82	0.73	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.74	11.23	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	11.72	11.72	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	8.56	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	10.16	11.06	0.60	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	5.06	6.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.90	11.88	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	8.45	10.72	0.32	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	12.14	8.74	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	11.88	11.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.04	10.92	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.89	13.06	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	7.52	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	9.88	10.05	0.33	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	8.19	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	16.13	14.78	0.00	1.06
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.97	16.07	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.79	16.06	0.38	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	15.50	9.09	0.53	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	6.83	7.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	11.11	12.61	0.00	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	14.41	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.92	14.07	0.51	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.22	10.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.49	15.56	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	14.54	15.75	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.69	12.54	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	11.12	13.47	0.00	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	17.03	12.65	0.52	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	8.45	9.38	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.15	15.11	0.96	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	13.56	9.27	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	4.68	8.77	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	13.25	13.55	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	9.50	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.65	9.15	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	12.99	10.95	0.25	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	13.34	5.72	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.49	12.08	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.74	14.18	0.85	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	8.70	10.44	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	9.45	5.67	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.22	10.68	0.34	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	11.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	10.56	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.72	13.29	0.86	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	13.84	13.84	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.83	8.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	13.10	14.25	0.69	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	12.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	17.80	9.15	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	11.15	12.18	0.41	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	14.69	6.73	0.00	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.13	9.08	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	10.42	13.08	0.22	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	12.21	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.97	8.31	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	12.45	10.33	1.06	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	10.18	11.99	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	37.21	17.44	2.09	0.86
Astrocyte - cerebellum, donor2	11580-120F5	40.05	34.75	1.54	2.23
Astrocyte - cerebellum, donor3	11661-122F5	19.30	10.91	1.89	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	21.26	9.76	1.05	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	35.91	16.66	1.94	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	34.61	20.58	2.83	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	18.35	11.12	0.92	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	18.42	11.78	2.63	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	17.75	10.13	1.02	0.68
Basophils, donor1	12241-129G9	13.60	5.75	0.26	0.78
Basophils, donor2	12242-129H1	27.78	10.82	1.08	0.36
Basophils, donor3	12243-129H2	15.29	7.50	0.59	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	19.40	11.00	0.65	1.51
Bronchial Epithelial Cell, donor2	11591-120G7	16.00	18.74	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	21.52	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	20.71	20.08	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	19.76	24.75	0.62	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	15.20	26.25	1.38	1.61
Bronchial Epithelial Cell, donor7	11769-123I5	16.55	20.33	0.00	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	20.61	10.82	1.75	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	18.87	7.69	2.33	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	34.86	14.39	1.60	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	10.34	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	19.72	12.96	0.00	1.13
CD14+ Monocytes, donor2	11305-117B9	12.81	9.09	0.19	0.19
CD14+ Monocytes, donor3	11381-118B4	14.71	7.03	0.44	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	11.89	3.11	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	10.61	2.27	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	9.53	2.63	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	4.63	4.19	0.14	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	8.45	3.02	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	11.61	4.26	0.24	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.18	2.51	0.33	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	5.52	4.14	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	8.43	2.23	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2.94	1.96	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	8.01	3.38	0.36	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.88	2.83	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	7.73	3.51	0.47	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	17.95	3.70	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	11.09	5.55	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	3.27	2.68	0.15	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.99	4.79	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	5.20	2.29	0.21	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.49	2.52	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	10.41	5.88	1.13	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	8.29	3.06	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	5.38	3.77	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	8.90	5.06	0.00	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	9.26	3.37	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4.04	2.94	0.18	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	7.40	2.82	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	8.34	3.07	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	3.49	1.74	0.35	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	12.27	5.95	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	7.11	2.80	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4.50	4.50	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	8.81	2.78	0.00	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.03	3.02	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	5.89	3.05	0.22	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	5.54	2.54	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	4.55	3.25	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	14.79	5.14	0.16	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	7.51	1.75	0.35	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	13.60	6.69	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	6.63	2.81	0.00	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	5.49	3.51	0.66	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	6.53	1.89	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	58.94	22.36	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	38.64	21.70	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	44.53	13.46	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	37.85	15.46	1.60	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	37.52	27.34	0.54	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	44.22	21.06	0.70	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	39.22	19.61	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	32.96	19.77	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	70.68	49.31	1.64	1.64
CD19+ B Cells, donor2	11624-122B4	55.86	27.57	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	50.48	39.88	1.51	2.52
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	21.82	7.27	0.40	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	18.78	10.39	0.40	1.20
CD34+ Progenitors, donor1	11545-120B6	34.14	1.00	2.01	1.00
CD34+ Progenitors, donor2	11625-122B5	20.79	13.48	1.69	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	25.55	8.64	1.50	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	25.71	9.02	1.13	0.00
CD4+ T Cells, donor1	11225-116C1	49.27	15.71	3.21	1.07
CD4+ T Cells, donor2	11306-117C1	46.54	26.94	3.06	0.00
CD4+ T Cells, donor3	11382-118B5	45.75	25.62	2.44	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	24.50	7.91	1.02	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	24.03	9.43	0.90	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	29.32	9.20	1.15	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	27.02	8.06	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	23.18	11.94	3.51	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	23.07	6.59	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	15.61	10.26	0.72	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	26.27	9.49	1.36	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	26.92	9.03	0.97	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	26.45	13.00	2.69	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	32.49	12.58	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	29.48	10.12	0.44	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	19.82	5.48	1.26	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	26.18	10.18	0.83	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	22.05	5.01	1.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	41.61	12.78	1.63	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	45.02	18.22	1.07	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	53.80	21.52	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	30.22	11.13	0.93	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	31.84	12.35	1.08	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	37.20	11.14	1.26	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	35.39	18.20	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	23.83	11.26	1.30	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	30.94	9.59	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	42.56	10.39	0.49	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	23.08	7.39	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	34.90	4.19	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	37.39	12.74	1.94	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	54.48	16.93	1.72	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	40.04	23.10	3.08	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	39.75	8.24	0.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	37.39	8.31	2.77	1.38
CD8+ T Cells, donor1	11226-116C2	55.33	18.99	0.98	1.96
CD8+ T Cells, donor2	11307-117C2	44.30	29.66	0.75	1.13
CD8+ T Cells, donor3	11383-118B6	49.49	21.71	3.03	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	6.65	2.75	0.69	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	7.67	0.72	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	5.47	2.74	0.55	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.20	2.70	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.24	2.88	0.48	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.55	0.91	0.91	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	5.65	2.17	0.87	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	7.37	3.16	0.26	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	7.04	2.35	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	5.43	1.51	0.91	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	5.81	3.20	0.87	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	8.26	4.26	1.07	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.50	3.94	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	4.10	2.28	0.00	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	4.48	2.98	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	5.04	1.44	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.06	1.15	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8.25	2.83	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	8.24	1.58	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	7.38	3.69	0.31	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	5.77	3.53	1.28	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	4.59	3.44	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.09	1.58	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	0.76	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	4.01	2.41	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	2.80	1.40	2.10	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	3.01	1.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	20.11	25.59	0.00	3.66
Cardiac Myocyte, donor2	11605-120I3	22.23	19.27	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	19.26	18.84	1.05	1.16
Chondrocyte - de diff, donor1	11261-116G1	31.89	27.39	0.00	2.77
Chondrocyte - de diff, donor2	11338-117F6	24.17	16.70	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	22.53	29.92	0.68	1.25
Chondrocyte - re diff, donor2	11339-117F7	5.37	21.49	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	21.84	18.60	0.81	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	21.80	10.10	1.38	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	25.44	14.11	0.43	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	18.41	13.19	1.24	0.97
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	47.41	40.35	2.57	3.94
Corneal Epithelial Cells, donor1	11526-119I5	14.93	8.78	0.00	1.10
Corneal Epithelial Cells, donor2	11606-120I4	12.51	10.24	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	17.13	20.96	1.02	2.05
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	15.19	6.11	0.50	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	8.83	6.31	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.34	5.29	0.00	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	45.78	12.98	2.39	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	43.09	16.32	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	43.56	15.00	3.39	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	20.85	14.34	1.17	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	24.06	6.45	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	36.20	22.34	1.41	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	29.10	27.92	0.39	0.79
Endothelial Cells - Artery, donor1	11264-116G4	19.49	18.62	0.58	0.58
Endothelial Cells - Artery, donor2	11341-117F9	17.88	14.35	1.65	0.71
Endothelial Cells - Artery, donor3	11413-118E9	21.56	15.08	0.88	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	23.72	11.08	1.77	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	20.39	10.65	1.52	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	19.45	12.40	0.00	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	22.58	14.86	0.89	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	17.70	14.58	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	26.37	19.85	1.56	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	28.41	16.40	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	18.87	9.96	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	30.44	18.76	1.49	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	34.11	23.46	2.82	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	38.71	23.69	2.08	0.85
Endothelial Cells - Vein, donor1	11267-116G7	29.58	13.65	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	18.86	13.27	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	29.99	25.44	0.63	0.63
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	14.85	11.55	0.00	0.00
Eosinophils, donor3	12246-129H5	7.13	10.70	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	14.17	10.75	0.49	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	24.96	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	44.75	75.95	0.41	6.16
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.74	9.53	0.11	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	21.23	20.91	0.54	1.08
Fibroblast - Aortic Adventitial, donor1	11245-116E3	25.71	21.59	1.46	1.09
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	19.11	20.47	0.41	2.05
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.04	16.77	0.53	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	22.92	18.18	0.79	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	27.24	26.24	0.66	1.99
Fibroblast - Cardiac, donor1	11268-116G8	27.22	26.31	0.91	1.81
Fibroblast - Cardiac, donor2	11345-117G4	40.93	26.53	0.76	2.27
Fibroblast - Cardiac, donor3	11417-118F4	19.40	19.24	0.95	0.79
Fibroblast - Cardiac, donor4	11452-119A3	27.28	18.49	0.30	0.91
Fibroblast - Cardiac, donor5	11456-119A7	20.30	20.94	0.76	1.02
Fibroblast - Cardiac, donor6	11460-119B2	25.47	23.19	0.91	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	20.50	8.31	0.67	1.07
Fibroblast - Choroid Plexus, donor2	11572-120E6	11.65	9.92	0.00	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	30.76	23.44	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	37.82	16.38	1.15	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	21.20	9.84	0.68	0.34
Fibroblast - Dermal, donor1	11269-116G9	13.62	18.31	0.47	0.47
Fibroblast - Dermal, donor2	11346-117G5	20.28	14.15	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	17.04	16.80	0.60	0.60
Fibroblast - Dermal, donor4	11450-119A1	25.44	18.88	1.81	0.68
Fibroblast - Dermal, donor5	11454-119A5	32.80	19.19	1.05	0.52
Fibroblast - Dermal, donor6	11458-119A9	35.25	23.06	0.81	0.65
Fibroblast - Gingival, donor1	11237-116D4	21.66	19.16	0.62	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	33.54	42.44	1.05	0.79
Fibroblast - Gingival, donor2	11318-117D4	28.20	17.92	1.32	0.40
Fibroblast - Gingival, donor3	11394-118C8	21.27	22.72	0.68	1.55
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	19.74	11.43	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	20.62	20.97	0.70	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	35.70	32.89	1.09	1.09
Fibroblast - Gingival, donor6 (control)	11922-125H5	31.24	20.83	0.54	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	35.99	26.11	0.35	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	31.00	32.47	0.73	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	28.09	35.86	2.05	2.05
Fibroblast - Gingival, donor8 (control)	11926-125H9	37.19	30.17	3.62	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	25.83	22.89	0.59	1.32
Fibroblast - Lung, donor1	11270-116H1	20.39	13.59	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	29.84	5.97	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	26.17	19.42	1.27	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	59.98	55.81	2.50	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	27.97	22.38	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	17.63	22.11	0.28	0.84
Fibroblast - Mammary, donor1	11540-120B1	38.57	19.49	0.81	3.25
Fibroblast - Mammary, donor2	11620-122A9	31.95	11.98	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	17.87	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	31.04	15.32	0.58	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	35.04	25.48	1.21	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	24.78	18.05	0.92	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	32.06	26.33	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	27.81	44.01	1.62	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	24.82	23.54	0.81	1.16
Fibroblast - Pulmonary Artery, donor1	11250-116E8	20.89	13.82	0.88	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	44.09	42.67	1.42	3.66
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	32.07	16.71	0.67	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	13.05	12.65	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	50.01	31.95	1.59	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	22.74	15.81	0.53	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	27.00	23.65	0.20	1.77
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	28.58	20.76	0.90	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	20.19	22.89	0.43	1.94
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	33.66	39.48	0.76	2.78
Fibroblast - skin normal, donor1	11553-120C5	25.92	27.07	0.16	2.95
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	36.09	31.88	1.40	1.80
Fibroblast - skin normal, donor2	11561-120D4	29.03	24.31	0.40	1.31
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	42.01	38.69	0.60	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	28.08	20.46	1.33	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	19.32	20.17	0.17	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	29.56	22.66	0.66	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	30.89	27.48	0.85	1.38
Fibroblast - skin walker warburg, donor1	11554-120C6	31.04	17.88	1.35	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	19.45	22.90	0.47	1.88
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	18.30	7.84	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	17.68	10.05	0.35	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	10.93	11.71	0.26	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	13.54	8.18	0.26	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	21.44	10.72	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	17.23	6.38	1.91	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	23.96	15.12	2.57	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	26.47	19.30	1.10	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	31.97	15.53	3.20	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	31.70	13.67	5.15	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	29.08	15.86	3.70	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	32.94	18.92	0.65	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	19.02	17.25	2.21	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	15.69	8.48	2.54	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	17.49	10.84	2.83	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	9.40	10.75	1.61	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	22.80	14.00	2.60	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	18.13	10.52	2.08	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	14.84	5.90	2.03	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	22.13	10.72	2.05	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	18.81	10.84	2.49	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	16.39	10.49	2.19	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	19.50	10.64	0.59	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	25.27	13.99	1.75	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	19.44	8.71	1.56	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	22.18	13.51	2.62	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	21.71	13.40	2.21	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	22.61	12.50	2.22	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	22.06	19.15	2.29	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.66	11.95	0.85	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	24.34	16.16	2.10	1.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.55	11.56	1.66	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	23.48	8.98	0.61	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.87	11.76	1.24	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	25.02	16.83	2.65	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	23.51	16.51	2.33	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	17.19	14.33	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	20.42	14.64	1.72	1.35
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	18.48	14.26	2.11	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	15.72	22.13	1.28	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	22.46	17.25	2.56	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	21.35	13.44	1.58	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	13.99	15.20	3.34	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	20.80	14.95	1.78	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	17.78	10.76	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	17.39	12.34	1.40	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	22.22	14.54	1.57	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	15.51	8.82	1.34	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	16.98	10.25	1.38	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	16.97	11.92	1.55	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	17.89	10.57	0.54	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	18.25	16.41	1.47	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	19.74	17.55	1.32	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	21.82	20.83	1.98	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	18.07	15.96	0.79	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	18.76	15.13	1.01	1.82
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	16.01	16.27	0.25	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	15.33	6.37	1.99	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	12.79	10.63	1.85	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	23.53	13.30	3.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	19.09	11.89	1.88	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	11.58	5.93	1.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	14.30	6.92	3.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	4.95	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	15.47	11.99	2.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	22.46	12.84	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	26.08	13.91	5.22	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	15.62	4.56	2.60	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	19.35	8.65	1.24	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	16.78	6.71	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	18.30	10.13	2.29	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	18.45	9.23	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	19.40	6.04	2.23	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	20.04	7.47	1.02	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	8.35	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	20.04	8.59	1.72	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	15.10	6.22	1.78	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	15.25	6.78	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	21.95	9.11	1.66	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	20.02	8.51	1.15	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	21.53	9.61	1.15	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	15.97	8.15	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	16.72	15.38	1.34	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	23.50	9.63	1.16	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	33.55	11.98	2.40	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	17.39	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	19.35	12.27	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	22.93	12.07	3.02	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	20.86	11.70	2.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	23.53	9.57	1.60	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	25.65	12.33	2.47	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	25.97	20.07	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	24.50	12.25	0.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	28.97	17.12	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	29.67	11.87	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	22.68	7.76	1.79	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.98	6.31	1.46	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	13.70	15.98	1.14	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	14.97	27.44	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	31.48	23.61	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	12.69	15.86	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	8.77	14.20	0.00	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	23.32	29.59	0.46	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	26.67	30.89	0.68	1.86
Hep-2 cells mock treated, biol_rep3	11900-125F1	32.08	32.08	1.14	2.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	27.00	33.89	0.98	2.08
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	27.72	32.88	1.07	3.01
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	29.06	25.40	1.08	2.58
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	17.31	22.17	0.50	1.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	25.22	19.56	0.69	2.57
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	14.10	20.18	0.64	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	29.10	16.23	2.80	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	35.92	23.37	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	7.93	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	36.33	22.93	1.41	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	26.15	14.53	0.00	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	19.06	11.01	0.70	0.70
Hepatocyte, donor1	11523-119I2	20.58	10.90	0.00	0.00
Hepatocyte, donor2	11603-120I1	16.16	15.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	19.02	16.57	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	26.76	11.10	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	26.57	25.17	0.52	1.92
Iris Pigment Epithelial Cells, donor1	11530-119I9	10.43	6.86	0.96	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	9.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	5.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	12.99	4.87	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1.67	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	3.97	1.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	4.43	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	5.67	1.89	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	6.19	1.55	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	5.81	5.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	9.66	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	7.33	3.26	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	7.56	5.04	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	5.63	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	5.54	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	6.61	3.78	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	5.44	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	5.38	2.15	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	11.43	1.27	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.74	2.55	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	5.71	1.43	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	6.48	2.16	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	14.05	8.78	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	5.56	4.17	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	9.59	4.36	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	6.97	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	6.40	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	8.31	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	8.28	0.92	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	2.11	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	11.67	8.49	0.41	0.41
Keratinocyte - epidermal, donor2	11349-117G8	9.96	7.61	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	16.28	15.43	1.33	0.47
Keratinocyte - oral, donor1	11251-116E9	14.08	10.67	0.23	0.23
Keratocytes, donor1	11527-119I6	39.54	12.38	1.03	1.03
Keratocytes, donor2	11607-120I5	31.64	21.09	0.00	2.34
Keratocytes, donor3	11688-122I5	18.77	11.26	0.79	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	28.57	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	14.02	11.87	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	13.72	6.00	1.38	0.69
Lens Epithelial Cells, donor3	11690-122I7	13.82	15.24	0.71	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	28.70	14.35	0.24	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.91	9.77	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	21.88	12.12	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	16.13	10.22	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	20.17	10.72	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	18.87	13.69	0.97	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	20.11	7.39	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	18.46	6.83	1.01	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	20.27	16.05	0.28	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	16.61	9.49	1.19	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	15.12	7.95	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	20.18	12.22	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	23.00	9.06	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	19.08	10.73	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	18.82	11.13	0.69	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	19.40	7.08	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	15.90	5.92	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	23.42	13.91	0.55	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	22.38	10.20	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	14.35	9.66	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	24.15	12.20	1.00	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	17.46	9.21	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	13.73	9.16	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	22.86	11.96	0.76	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	21.25	9.85	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	15.49	8.79	0.63	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	21.05	9.47	0.75	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	15.82	9.63	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	13.92	7.15	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	18.34	12.83	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	20.84	7.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	14.22	9.26	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	20.44	12.02	0.50	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	18.51	8.51	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	13.59	7.66	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	16.09	11.96	0.96	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	15.12	6.75	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	19.48	7.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	20.71	10.36	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	21.69	7.47	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	15.03	3.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	19.14	11.67	0.47	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	13.61	5.37	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	12.41	7.51	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	16.48	11.30	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	25.25	15.59	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	11.53	7.17	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	21.18	10.44	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	9.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	15.34	9.97	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	8.16	7.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	13.12	9.31	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.03	10.55	1.41	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	12.14	6.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	8.76	5.15	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	8.33	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	8.37	9.50	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	15.41	8.72	0.00	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	14.86	6.75	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	15.99	10.84	0.81	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	7.70	7.19	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	15.17	8.47	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	13.99	3.33	0.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	21.39	12.73	0.51	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	11.74	10.67	0.80	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	15.12	11.90	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	13.50	7.98	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	14.68	22.02	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	11.04	11.45	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	11.77	9.53	0.56	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	16.49	6.18	0.00	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	15.97	9.58	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	11.36	5.98	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	12.17	11.07	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	15.55	14.49	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	10.69	9.96	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	5.76	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	13.82	11.13	0.38	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	15.85	9.06	1.13	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	18.05	9.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	16.72	14.91	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	15.08	10.05	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	15.68	11.95	0.00	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	16.72	13.75	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	11.63	5.17	1.29	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	16.27	10.28	0.00	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	14.66	10.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	17.50	9.65	2.41	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.22	12.80	0.71	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	13.40	11.69	1.03	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	15.57	10.20	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	12.79	10.10	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	13.71	10.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	15.12	6.98	0.00	3.49
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	9.52	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	24.01	17.21	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	13.08	8.72	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	17.63	11.50	0.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	15.78	14.31	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	11.29	10.35	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	20.62	13.58	1.51	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	17.57	9.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	30.98	15.49	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	15.59	12.47	2.23	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	18.77	16.03	0.00	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	10.56	11.22	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	18.16	17.12	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	16.19	19.69	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	16.21	8.95	1.68	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	20.76	15.02	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	18.51	15.43	0.77	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	12.66	10.63	1.52	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	19.22	15.86	2.40	2.88
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	17.89	14.71	0.40	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	17.62	19.44	0.00	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.83	10.38	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	21.28	15.58	0.38	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	28.92	17.04	0.52	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	19.95	10.88	0.60	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	20.92	13.94	0.63	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	22.92	11.73	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	21.84	16.67	0.57	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	26.23	18.00	0.00	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	18.39	16.27	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	26.10	14.75	0.00	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	26.63	21.63	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	20.36	6.26	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	22.13	14.20	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	23.23	16.26	0.93	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	17.40	12.71	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	22.99	9.09	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	21.01	21.01	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	20.19	14.68	0.92	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.01	11.56	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	17.10	20.52	0.57	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	18.41	16.10	1.53	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	16.42	8.75	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	24.50	16.93	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	23.40	12.48	1.04	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	19.23	9.95	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	22.86	10.39	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	6.15	1.14	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	6.06	1.65	0.73	0.37
Macrophage - monocyte derived, donor3	11389-118C3	6.69	2.75	0.79	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	6.90	4.25	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	10.62	8.87	0.16	0.63
Mallassez-derived cells, donor3	11930-125I4	10.15	7.92	0.28	0.14
Mammary Epithelial Cell, donor1	11273-116H4	30.39	18.63	0.60	1.99
Mammary Epithelial Cell, donor2	11350-117G9	28.38	29.82	0.87	1.16
Mammary Epithelial Cell, donor3	11422-118F9	26.94	31.18	0.25	2.00
Mast cell - stimulated, donor1	11487-119E2	3.39	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	11.35	2.16	0.87	0.43
Mast cell, donor2	11565-120D8	29.12	7.13	1.19	1.19
Mast cell, donor3	11566-120D9	32.19	8.78	0.90	0.45
Mast cell, donor4	11567-120E1	25.35	7.98	1.24	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	16.97	4.55	0.67	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	12.84	3.50	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	16.18	5.16	0.57	0.34
Mast cell, expanded, donor8	11941-126A6	23.93	5.69	1.00	0.50
Melanocyte - dark, donor1	11502-119F8	24.68	18.11	0.99	0.40
Melanocyte - dark, donor2	11582-120F7	24.23	23.19	0.00	2.77
Melanocyte - dark, donor3	11663-122F7	17.89	8.69	0.87	0.72
Melanocyte - light, donor1	11274-116H5	22.10	16.69	1.18	1.65
Melanocyte - light, donor2	11351-117H1	19.79	20.47	0.00	0.00
Melanocyte - light, donor3	11423-118G1	13.01	13.01	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	20.51	16.14	1.04	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	11.56	7.26	0.81	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	17.68	11.25	0.80	0.54
Meningeal Cells, donor1	11493-119E8	52.48	26.05	2.23	1.24
Meningeal Cells, donor2	11573-120E7	23.33	16.29	1.76	1.32
Meningeal Cells, donor3	11654-122E7	27.06	19.32	1.14	0.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	29.09	23.95	0.86	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	23.85	27.67	0.30	2.92
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	14.46	15.77	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	35.32	27.47	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	38.75	20.81	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	30.92	25.62	1.06	2.54
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	22.62	28.15	1.01	4.02
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	49.44	22.85	1.10	1.76
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	40.18	22.65	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	41.33	33.55	2.05	2.66
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	15.79	15.37	0.83	1.25
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	20.82	14.50	1.12	1.86
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	15.66	13.03	0.53	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	10.39	11.28	0.30	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	16.35	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	25.62	17.93	1.92	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	34.03	20.20	1.06	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	13.13	10.95	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	23.22	11.61	1.45	1.45
Mesothelial Cells, donor1	11247-116E5	18.56	13.26	0.53	2.12
Mesothelial Cells, donor2	12156-128G5	12.51	14.01	1.50	0.00
Mesothelial Cells, donor3	11402-118D7	13.95	14.74	0.94	0.94
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	10.80	6.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	6.90	1.97	0.74	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	9.42	2.94	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	4.96	2.17	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	4.36	3.11	0.83	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	5.01	2.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.98	4.65	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	5.69	2.64	0.61	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	5.54	2.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	4.94	1.90	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	14.47	7.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	1.70	1.70	0.42	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	5.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	5.96	2.09	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	3.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	33.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.27	2.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.84	2.61	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	4.42	1.11	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	4.37	1.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	4.84	1.89	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.10	1.63	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	1.72	1.07	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4.89	1.33	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	2.41	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	5.58	3.04	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	4.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	3.81	2.45	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	6.76	2.06	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2.40	0.96	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.00	2.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	4.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.00	1.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	3.94	1.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.12	2.56	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	4.46	1.24	0.25	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.18	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	3.76	1.03	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	5.69	0.88	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.10	3.91	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3.09	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	3.33	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.66	1.75	0.00	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	2.41	1.81	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	3.76	2.50	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	4.62	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	5.12	1.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	4.97	2.63	0.28	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	4.15	2.33	0.00	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.86	2.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	3.81	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	3.47	1.87	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	5.69	1.80	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	3.81	2.40	0.57	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	2.87	1.59	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	4.42	2.87	0.22	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	6.07	2.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	3.98	2.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	6.64	1.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.08	3.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	6.17	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	3.75	4.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	13.19	5.36	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	6.55	1.19	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	3.29	1.31	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	6.72	2.17	0.00	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	1.86	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	5.63	2.63	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	4.79	2.13	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.09	1.92	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.16	2.21	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	4.03	1.47	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	7.78	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1.60	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	3.03	3.03	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	2.11	2.11	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	3.26	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	18.10	14.00	0.43	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	19.86	9.41	1.57	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	22.03	24.03	0.00	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	25.88	44.66	0.00	5.01
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	51.53	56.47	1.14	4.56
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	46.28	68.62	3.19	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.28	18.36	0.00	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	11.03	16.54	3.68	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.56	16.32	0.42	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	27.66	42.07	0.70	3.49
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.86	16.48	0.54	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	31.12	21.02	0.42	1.26
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	13.90	17.37	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	16.24	21.38	0.00	2.17
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	16.09	23.35	0.23	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.00	16.66	0.16	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	23.33	24.79	0.55	1.64
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	11.67	19.63	0.00	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	19.81	18.01	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.39	21.99	0.00	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.36	19.19	0.00	1.79
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	26.81	29.10	0.00	1.23
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	13.36	17.58	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	18.39	14.71	0.00	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	14.78	20.89	0.32	2.25
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	13.45	28.28	0.00	3.10
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	27.81	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	19.83	27.40	1.11	2.90
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	19.90	26.67	0.85	3.39
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	20.89	21.36	0.24	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	18.03	27.47	0.00	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	27.08	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.99	16.33	0.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	28.40	32.91	1.35	2.25
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.48	23.01	0.00	2.38
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	10.22	21.36	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	22.70	29.13	0.76	2.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	18.25	26.72	0.33	3.58
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.89	16.12	0.00	2.61
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	35.28	51.56	0.00	6.78
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	16.76	19.40	0.00	4.41
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	14.63	14.63	0.00	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	14.88	25.79	0.50	3.97
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	19.91	31.39	0.00	3.45
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	24.80	21.78	0.30	1.81
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	34.70	31.83	0.22	4.20
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.20	23.72	0.00	3.39
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	11.58	25.00	0.00	4.88
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	19.83	44.38	0.31	3.46
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	14.53	19.98	0.00	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	23.73	31.65	0.00	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	22.67	24.94	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	5.06	5.06	0.00
Myoblast, donor1	11241-116D8	18.14	19.63	0.50	2.11
Myoblast, donor2	11322-117D8	42.39	45.45	0.38	2.88
Myoblast, donor3	11398-118D3	43.39	31.61	1.35	4.88
NK T cell leukemia cell line:KHYG-1	10777-110G3	24.81	10.65	1.75	0.44
Natural Killer Cells, donor1	11230-116C6	50.43	15.68	1.54	2.46
Natural Killer Cells, donor2	11311-117C6	39.81	18.09	1.51	1.81
Natural Killer Cells, donor3	11387-118C1	36.99	18.96	1.84	1.66
Neural stem cells, donor1	11275-116H6	35.93	15.97	1.09	1.81
Neural stem cells, donor2	11352-117H2	34.66	13.48	0.00	0.00
Neurons, donor1	11494-119E9	28.45	13.65	4.55	1.14
Neurons, donor2	11574-120E8	34.79	7.49	4.18	1.10
Neurons, donor3	11655-122E8	44.40	25.49	1.64	0.00
Neutrophils, donor1	11233-116C9	8.35	4.64	0.00	0.00
Neutrophils, donor2	11314-117C9	5.80	5.80	0.00	2.90
Neutrophils, donor3	11390-118C4	7.33	4.28	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	18.88	21.37	0.47	0.83
Nucleus Pulposus Cell, donor2	11409-118E5	14.33	16.61	0.00	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	14.64	16.45	0.80	0.80
Olfactory epithelial cells, donor1	11933-125I7	37.58	53.68	0.69	3.58
Olfactory epithelial cells, donor2	11934-125I8	29.24	39.37	0.14	1.88
Olfactory epithelial cells, donor3	11935-125I9	25.20	37.80	0.23	1.36
Olfactory epithelial cells, donor4	11936-126A1	23.08	22.79	0.49	0.88
Oligodendrocyte - precursors, donor1	11496-119F2	32.50	38.52	0.60	7.82
Osteoblast - differentiated, donor1	11276-116H7	14.04	19.57	0.00	1.28
Osteoblast - differentiated, donor2	11353-117H3	13.72	13.72	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	11.79	9.93	1.24	0.00
Osteoblast, donor1	11277-116H8	29.71	22.67	0.98	0.98
Osteoblast, donor2	11354-117H4	42.14	22.47	0.70	0.70
Osteoblast, donor3	11426-118G4	36.97	42.48	1.42	2.49
Pancreatic stromal cells, donor1	11249-116E7	18.95	19.29	0.76	0.59
Pericytes, donor1	11491-119E6	23.81	19.36	0.67	1.78
Pericytes, donor2	11571-120E5	21.50	23.77	0.45	2.49
Pericytes, donor3	11652-122E5	23.60	32.76	0.20	0.81
Perineurial Cells, donor1	11499-119F5	20.46	13.79	1.24	1.47
Perineurial Cells, donor2	11579-120F4	21.35	28.43	0.37	1.10
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	36.34	7.33	1.91	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	20.81	10.28	0.98	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	31.06	12.29	0.91	0.39
Placental Epithelial Cells, donor1	11278-116H9	30.61	22.24	0.00	1.67
Placental Epithelial Cells, donor2	11355-117H5	7.76	11.09	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	25.72	26.31	0.98	1.37
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	28.48	25.95	0.00	3.48
Preadipocyte - breast, donor1	11467-119B9	23.64	22.70	0.75	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	27.80	34.46	0.91	2.22
Preadipocyte - breast, donor2	11328-117E5	24.77	28.82	1.35	1.35
Preadipocyte - omental, donor1	11468-119C1	23.76	27.49	0.85	1.17
Preadipocyte - omental, donor2	11329-117E6	31.86	25.32	0.00	2.18
Preadipocyte - omental, donor3	11403-118D8	32.80	38.10	0.29	3.72
Preadipocyte - perirenal, donor1	11469-119C2	33.47	22.64	0.00	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	35.63	41.15	0.31	3.69
Preadipocyte - subcutaneous, donor2	11356-117H6	36.12	44.62	0.71	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	35.08	34.40	0.51	1.87
Preadipocyte - visceral, donor1	11280-116I2	39.59	24.22	1.02	1.30
Preadipocyte - visceral, donor2	11357-117H7	25.31	23.47	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	36.47	39.18	0.52	2.09
Prostate Epithelial Cells (polarized), donor1	11253-116F2	21.72	20.21	0.91	1.81
Prostate Epithelial Cells, donor2	11331-117E8	14.76	14.76	0.14	0.81
Prostate Epithelial Cells, donor3	11404-118D9	32.27	48.74	0.37	4.84
Prostate Stromal Cells, donor1	11254-116F3	19.48	16.06	0.91	0.80
Prostate Stromal Cells, donor2	11332-117E9	19.90	18.47	0.72	0.90
Prostate Stromal Cells, donor3	11405-118E1	16.37	17.52	0.31	0.73
Renal Cortical Epithelial Cells, donor1	11516-119H4	21.90	14.96	1.46	2.19
Renal Cortical Epithelial Cells, donor2	11596-120H3	15.11	11.09	0.90	0.69
Renal Epithelial Cells, donor1	11517-119H5	37.03	18.26	1.52	0.00
Renal Epithelial Cells, donor2	11597-120H4	34.14	19.92	2.13	0.71
Renal Epithelial Cells, donor3	11678-122H4	15.99	10.69	0.42	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	30.64	24.51	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	29.92	24.39	1.75	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	36.19	28.86	0.67	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	18.63	9.98	1.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	36.31	14.75	1.32	0.44
Renal Mesangial Cells, donor2	11598-120H5	32.60	23.20	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	28.02	14.98	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	42.95	28.99	1.61	4.29
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	20.66	25.30	0.00	2.11
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	28.73	20.25	2.31	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	17.63	5.96	1.56	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	18.19	10.23	0.00	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	19.55	8.23	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	9.53	7.28	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	32.61	26.19	0.94	1.87
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	38.42	13.40	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	18.71	9.91	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	36.54	17.98	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	31.86	13.65	1.04	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	25.62	15.79	1.29	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	32.23	13.50	1.90	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	30.76	18.48	0.74	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	27.97	16.55	1.28	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	37.91	20.11	4.16	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	30.53	15.20	1.37	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	28.89	16.34	0.76	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	32.79	15.41	1.43	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	33.28	19.65	0.57	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	26.83	17.06	1.93	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	28.99	18.81	1.33	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	34.22	14.15	1.91	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	25.62	17.89	1.30	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	39.46	15.03	1.32	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	31.19	20.83	1.59	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	28.23	20.73	1.65	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	31.32	17.38	2.29	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	31.61	17.94	1.39	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	33.36	12.61	1.68	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	33.50	17.26	2.39	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	33.18	18.42	1.09	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	28.70	19.25	1.72	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	31.70	20.55	2.28	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	31.61	10.61	1.89	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	27.18	16.07	1.19	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	31.34	21.05	1.64	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	32.35	14.31	2.28	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	23.67	21.01	1.33	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	29.87	19.01	2.30	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	30.69	16.82	1.62	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	27.93	19.41	1.70	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	38.17	26.03	1.16	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	32.50	17.19	1.72	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	27.71	18.93	2.19	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	35.46	22.98	1.64	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	31.19	17.72	2.22	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	31.51	18.35	2.37	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	39.18	19.19	2.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	33.46	17.28	2.49	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	32.62	17.86	2.14	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	37.08	22.37	2.22	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	27.88	14.79	1.60	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	36.68	23.76	1.75	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	38.08	17.23	1.21	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	35.25	14.93	0.86	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	79.91	33.33	2.18	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	46.85	18.25	1.83	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	27.43	13.26	2.41	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	45.46	25.11	1.58	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	50.32	26.66	2.10	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	35.89	19.48	1.65	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	35.00	24.12	0.85	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	64.30	25.24	1.20	2.40
Schwann Cells, donor1	11498-119F4	33.66	33.48	2.07	2.44
Schwann Cells, donor2	11578-120F3	13.61	6.80	0.00	0.00
Schwann Cells, donor3	11659-122F3	22.13	12.49	1.10	1.10
Sebocyte, donor1	11220-116B5	16.98	6.57	1.10	1.10
Sebocyte, donor2	11301-117B5	10.11	9.19	0.00	0.00
Sebocyte, donor3	11378-118B1	10.51	12.16	0.00	0.62
Sertoli Cells, donor1	11255-116F4	21.54	31.48	1.66	3.31
Sertoli Cells, donor2	11333-117F1	25.42	25.42	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	26.22	12.76	1.41	0.53
Skeletal Muscle Cells, donor2	11358-117H8	13.01	11.57	2.17	0.00
Skeletal Muscle Cells, donor3	11430-118G8	39.29	29.26	1.67	0.84
Skeletal Muscle Cells, donor4	11451-119A2	30.63	20.74	1.10	0.79
Skeletal Muscle Cells, donor5	11455-119A6	22.89	16.95	0.89	0.45
Skeletal Muscle Cells, donor6	11459-119B1	29.86	26.78	1.85	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	22.30	12.98	1.01	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.98	14.84	1.00	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	32.44	27.08	1.39	1.29
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	27.55	19.63	1.01	2.27
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	28.23	18.09	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	19.26	20.23	0.55	0.69
Skin - palm, donor1	10286-104F7	59.09	56.41	0.00	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	12.25	12.40	0.29	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	80.15	31.90	2.45	13.90
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	11.81	10.26	0.00	1.56
Small Airway Epithelial Cells, donor1	11256-116F5	14.60	14.04	0.14	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	20.68	22.51	0.56	1.69
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	86.90	65.13	2.11	7.61
Small Airway Epithelial Cells, donor3	11406-118E2	16.34	16.26	0.07	0.97
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	23.45	20.68	0.31	2.16
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	21.79	23.79	0.44	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	28.22	21.16	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	17.90	11.27	0.88	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	27.96	24.81	1.18	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	36.31	17.00	0.77	4.64
Smooth Muscle Cells - Bladder, donor1	11519-119H7	14.01	11.01	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	20.76	14.77	0.80	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	17.95	29.04	0.89	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	22.15	39.82	0.64	1.66
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	16.61	5.21	0.98	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	21.85	12.40	0.59	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	13.81	13.67	0.57	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	20.99	7.81	0.65	1.46
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	11.26	11.57	0.00	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	26.52	9.34	1.26	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	21.93	10.97	2.38	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	19.32	9.73	0.29	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	16.14	18.30	0.65	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	21.52	18.79	1.05	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	25.68	29.23	0.93	1.86
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	20.48	17.25	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	25.40	21.22	0.60	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	32.09	11.95	0.34	1.71
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	19.24	18.30	0.86	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	31.10	40.46	0.40	2.82
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	15.93	21.85	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	21.74	36.83	0.60	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	28.88	19.34	1.59	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	21.97	18.51	0.80	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.78	19.28	0.38	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	15.22	21.31	0.51	1.52
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	30.00	32.42	2.11	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	23.26	18.75	0.75	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	28.43	7.75	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	34.88	21.39	1.40	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	20.20	29.79	1.01	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.36	31.65	0.00	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	22.12	9.73	0.59	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	29.16	18.41	1.33	1.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	18.69	14.95	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	27.20	37.27	0.29	2.73
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	22.95	25.50	0.51	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	26.32	30.84	0.75	1.88
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	19.01	13.83	0.70	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	14.91	15.75	0.59	0.92
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.14	6.19	1.43	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	27.16	39.39	0.49	1.22
Smooth Muscle Cells - Uterine, donor1	11258-116F7	35.35	37.34	0.22	4.64
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.97	10.83	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	15.55	11.08	0.19	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	18.51	14.28	0.26	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	8.18	11.16	0.74	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	17.25	15.45	0.36	2.52
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	25.55	24.42	0.57	6.53
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	32.69	22.06	1.18	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	11.68	8.13	0.25	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	13.58	11.58	0.80	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	12.96	10.03	0.42	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	12.38	10.54	0.46	2.75
Synoviocyte, donor1	11291-117A4	63.46	79.28	0.67	4.88
Synoviocyte, donor2	11368-117I9	15.42	19.28	0.50	0.50
Synoviocyte, donor3	11440-118H9	19.66	19.44	0.00	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	38.95	25.37	2.14	2.86
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	19.82	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	21.07	15.98	0.69	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	15.05	10.04	0.43	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	9.66	15.08	0.39	1.93
Tracheal Epithelial Cells, donor3	11441-118I1	6.30	8.59	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	32.11	23.13	0.00	1.72
Urethra, donor2	10319-105A4	37.77	28.77	0.00	0.00
Urothelial Cells, donor1	11520-119H8	23.64	20.19	0.00	1.86
Urothelial Cells, donor2	11600-120H7	11.62	11.22	0.00	0.00
Urothelial Cells, donor3	11681-122H7	16.04	23.15	0.23	2.75
Urothelial cells, donor0	11216-116B1	25.19	40.34	0.89	3.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	27.58	7.12	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	32.88	14.30	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	15.06	7.53	0.00	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	25.83	6.89	0.34	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	31.96	7.55	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	21.87	6.25	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	21.11	6.42	1.84	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	15.52	10.04	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	13.20	5.06	0.99	0.37
Wilms' tumor cell line:HFWT	10597-108E3	124.97	201.53	0.00	21.12
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	41.90	97.48	0.28	4.75
achilles tendon, donor2	10292-104G4	18.60	20.67	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	10.20	2.55	1.02	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	37.38	15.32	3.95	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	35.14	17.57	3.21	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	36.46	16.05	1.90	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	7.87	5.90	1.69	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	18.40	5.50	1.06	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	14.16	9.26	4.36	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	6.61	7.93	1.76	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	9.80	7.35	1.23	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	61.74	49.31	1.55	3.88
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	2.76	2.21	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	15.60	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	19.98	10.92	1.16	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	20.45	8.28	1.81	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	20.16	7.01	3.21	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	10.22	6.04	2.79	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	13.98	7.81	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	4.30	2.76	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	10.24	5.12	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	8.49	2.73	0.61	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	5.05	4.81	0.72	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	14.03	8.46	1.11	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	12.67	4.67	1.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	3.72	1.86	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	5.27	4.52	1.13	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	47.10	22.68	4.36	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	29.99	26.24	5.62	0.00
adenocarcinoma cell line:IM95m	10796-110I4	33.91	48.75	0.47	3.06
adipose tissue, adult, pool1	10010-101C1	42.81	25.28	1.24	1.40
adipose, donor1	10184-103D4	20.52	14.66	1.17	2.93
adipose, donor2	10185-103D5	26.76	14.60	3.65	0.41
adipose, donor3	10186-103D6	27.77	12.80	1.63	1.09
adipose, donor4	10187-103D7	16.47	13.00	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	15.31	5.84	0.63	0.16
adrenal gland, adult, pool1	10081-102A9	21.83	18.19	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	16.81	6.67	2.13	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	31.80	17.15	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	38.72	86.02	0.46	4.87
amniotic membrane cells, donor2	12236-129G4	25.02	25.70	0.68	1.01
amniotic membrane cells, donor3	12237-129G5	32.11	77.19	0.59	6.48
amygdala - adult, donor10196	10167-103B5	33.20	35.57	0.00	3.56
amygdala, adult, donor10252	10151-102I7	53.13	61.84	2.03	4.06
amygdala, newborn, donor10223	10360-105E9	44.54	22.27	1.94	2.58
anaplastic carcinoma cell line:8305C	10428-106D5	17.70	15.15	1.91	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	16.33	9.27	1.32	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	41.42	28.39	4.01	0.67
aorta, adult, pool1	10052-101G7	53.94	68.45	1.77	2.55
appendix, adult	10189-103D9	36.09	23.29	3.49	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	21.67	8.25	0.34	0.69
artery, adult	10190-103E1	40.76	29.89	0.00	2.72
astrocytoma cell line:TM-31	10425-106D2	55.48	26.95	3.04	0.72
b cell line:RPMI1788	10427-106D4	12.64	6.39	1.34	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	40.51	61.32	0.55	3.88
bile duct carcinoma cell line:HuCCT1	10432-106D9	37.21	42.57	0.40	5.76
bile duct carcinoma cell line:TFK-1	10496-107C1	13.22	7.03	0.00	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	20.13	8.95	3.36	0.00
bladder, adult, pool1	10011-101C2	38.02	37.05	0.76	2.06
blood, adult, pool1	10053-101G8	11.07	6.64	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	40.25	50.52	0.00	7.71
bone marrow, adult	10192-103E3	31.04	35.77	0.67	2.70
brain, adult, donor1	10084-102B3	49.20	58.43	0.00	6.15
brain, adult, pool1	10012-101C3	40.98	33.52	1.78	3.34
brain, fetal, pool1	10085-102B4	82.81	21.37	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	17.51	17.51	0.99	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	31.95	22.22	0.12	1.37
breast, adult, donor1	10080-102A8	32.83	38.51	1.26	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	30.24	16.77	0.13	2.79
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	79.78	72.36	0.31	7.42
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	18.42	9.21	0.46	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	22.03	30.74	0.00	2.42
carcinoid cell line:NCI-H1770	10703-109H1	24.45	7.52	2.35	1.41
carcinoid cell line:NCI-H727	10735-110B6	19.25	18.92	1.31	1.53
carcinoid cell line:SK-PN-DW	10719-109I8	9.51	5.07	0.63	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	44.98	18.37	3.46	1.06
caudate nucleus - adult, donor10196	10177-103C6	65.63	62.17	2.30	6.91
caudate nucleus, adult, donor10252	10164-103B2	65.42	84.33	1.67	2.84
caudate nucleus, adult, donor10258	10379-105H1	89.40	108.51	1.53	4.58
caudate nucleus, newborn, donor10223	10354-105E3	60.06	39.92	0.37	2.20
cerebellum - adult, donor10196	10173-103C2	67.01	29.13	2.91	11.65
cerebellum, adult, donor10252	10166-103B4	93.94	75.37	4.06	5.98
cerebellum, adult, pool1	10083-102B2	63.81	48.98	2.07	8.62
cerebellum, newborn, donor10223	10357-105E6	117.07	39.02	2.49	4.98
cerebral meninges, adult	10188-103D8	37.82	35.05	2.02	3.53
cerebrospinal fluid, donor2	10294-104G6	24.85	24.85	0.00	3.65
cervical cancer cell line:D98-AH2	10552-107I3	12.08	11.07	0.00	0.58
cervical cancer cell line:ME-180	10553-107I4	23.20	16.90	0.33	1.66
cervix, adult, pool1	10013-101C4	58.27	62.57	1.15	3.36
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	20.20	15.61	0.84	1.11
chondrosarcoma cell line:SW 1353	10700-109G7	16.98	31.35	1.31	1.31
choriocarcinoma cell line:BeWo	10423-106C9	18.52	12.05	2.73	1.12
choriocarcinoma cell line:SCH	10785-110H2	15.89	12.81	0.74	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	29.17	15.89	2.13	0.71
chorionic membrane cells, donor1	12238-129G6	35.05	44.45	1.99	1.71
chorionic membrane cells, donor2	12239-129G7	29.83	37.68	0.60	2.39
chorionic membrane cells, donor3	12240-129G8	32.42	41.76	1.10	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	16.16	7.07	3.03	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	14.41	8.45	0.77	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	10.14	3.38	1.69	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	6.68	3.60	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	7.98	4.11	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	5.70	3.05	0.41	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	12.96	4.12	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	20.33	7.04	1.30	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	12.80	7.31	0.91	0.23
clear cell carcinoma cell line:TEN	10636-108I6	12.32	19.26	0.00	1.56
colon carcinoma cell line:CACO-2	10513-107D9	23.80	17.76	1.10	2.38
colon carcinoma cell line:COLO-320	10420-106C6	23.95	14.06	1.90	0.76
colon, adult, donor1	10082-102B1	53.55	45.22	1.19	0.00
colon, adult, pool1	10014-101C5	27.26	24.09	0.82	1.41
colon, fetal, donor1	10070-101I7	31.52	31.52	0.00	3.71
common myeloid progenitor CMP, donor1	12130-128D6	151.26	36.67	4.58	13.75
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	12.32	2.55	1.27	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	10.57	3.02	0.91	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	10.72	3.53	0.56	0.00
corpus callosum, adult, pool1	10042-101F6	70.10	56.39	2.76	6.74
cruciate ligament, donor2	10295-104G7	30.80	34.85	0.00	3.24
diaphragm, fetal, donor1	10069-101I6	49.76	56.18	0.80	5.62
diencephalon, adult	10193-103E4	50.64	42.96	0.72	4.32
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	21.81	9.41	1.84	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	25.13	23.85	0.77	1.54
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	13.72	8.91	0.72	0.24
ductus deferens, adult	10196-103E7	37.38	32.89	1.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	50.41	33.13	0.00	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	54.44	41.93	0.00	1.47
dura mater, adult, donor1	10041-101F5	37.41	25.68	1.32	1.07
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	58.18	17.32	2.22	2.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	43.56	12.61	1.58	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	22.20	32.06	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	26.03	39.96	0.61	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	35.20	42.92	0.62	2.16
embryonic pancreas cell line:2C6	10603-108E9	34.15	35.46	0.00	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	30.84	37.88	1.01	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	24.65	10.51	0.72	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	24.77	27.18	0.32	1.93
epidermoid carcinoma cell line:A431	10426-106D3	32.01	48.02	0.44	4.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	44.54	39.48	0.77	2.20
epididymis, adult	10197-103E8	35.37	35.79	1.67	2.51
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	18.81	4.44	1.77	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	10.22	3.93	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	31.45	33.02	1.18	1.31
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	24.90	30.90	0.69	0.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	27.78	32.71	0.90	0.90
esophagus, adult, pool1	10015-101C6	23.47	25.27	0.53	1.17
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	22.79	7.39	1.25	0.75
eye - muscle inferior rectus, donor1	10272-104E2	19.32	48.29	2.41	4.83
eye - muscle lateral, donor2	10298-104H1	16.83	25.25	2.10	6.31
eye - muscle medial, donor2	10299-104H2	25.30	59.53	0.00	7.44
eye - muscle superior, donor2	10297-104G9	22.93	34.39	0.00	4.59
eye - vitreous humor, donor1	10268-104D7	20.40	37.89	1.46	5.83
eye, fetal, donor1	10054-101G9	25.68	30.51	1.53	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	31.29	29.36	0.64	2.05
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	39.65	33.00	0.47	2.85
frontal lobe, adult, pool1	10040-101F4	65.49	44.57	2.25	4.88
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	52.24	48.94	0.60	7.51
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	19.02	20.12	0.55	1.19
gall bladder, adult	10198-103E9	40.32	37.42	0.97	2.17
gamma delta positive T cells, donor1	11937-126A2	48.32	18.25	2.15	0.54
gamma delta positive T cells, donor2	11938-126A3	38.47	17.93	1.12	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	49.21	71.18	0.63	5.70
gastric adenocarcinoma cell line:MKN45	10612-108F9	29.59	28.63	2.13	1.55
gastric cancer cell line:AZ521	10549-107H9	14.43	7.54	2.79	0.00
gastric cancer cell line:GSS	10560-108A2	17.39	13.73	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	8.45	7.54	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	33.62	22.14	0.23	1.15
giant cell carcinoma cell line:Lu99B	10433-106E1	23.37	17.35	0.70	1.68
glassy cell carcinoma cell line:HOKUG	10688-109F4	50.38	58.61	0.75	4.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	31.67	24.17	1.58	1.69
glioblastoma cell line:A172, tech_rep2	10444-106F3	36.09	31.60	1.83	2.25
glioblastoma cell line:T98G	10485-107A8	35.87	23.29	0.55	0.77
glioma cell line:GI-1	10413-106B8	13.18	9.37	0.88	0.59
globus pallidus - adult, donor10196	10175-103C4	56.13	48.11	0.00	10.20
globus pallidus, adult, donor10252	10161-103A8	69.32	84.70	0.73	6.35
globus pallidus, adult, donor10258	10367-105F7	79.41	46.55	0.00	5.48
globus pallidus, newborn, donor10223	10364-105F4	59.69	42.10	0.00	3.73
granulocyte macrophage progenitor, donor1	12131-128D7	203.11	48.94	7.34	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	40.32	50.24	1.60	1.60
hIPS +CCl2, biol_rep1	14383-156B9	18.82	11.02	0.00	0.92
hIPS +CCl2, biol_rep2	14384-156C1	10.97	6.86	1.83	2.29
hIPS +CCl2, biol_rep3	14385-156C2	16.75	11.59	1.29	0.64
hIPS, biol_rep1	14380-156B6	14.37	2.87	0.00	1.44
hIPS, biol_rep2	14381-156B7	10.97	6.86	0.69	1.37
hIPS, biol_rep3	14382-156B8	55.17	36.41	1.10	12.14
hairy cell leukemia cell line:Mo	10712-109I1	12.07	3.74	1.15	0.29
heart - mitral valve, adult	10205-103F7	46.64	33.78	0.90	2.09
heart - pulmonic valve, adult	10206-103F8	52.82	45.50	1.57	3.40
heart - tricuspid valve, adult	10207-103F9	75.77	100.75	4.16	4.16
heart, adult, diseased post-infarction, donor1	10050-101G5	49.79	65.09	0.41	4.49
heart, adult, diseased, donor1	10051-101G6	70.26	82.61	1.28	5.54
heart, adult, pool1	10016-101C7	49.45	60.48	2.07	3.91
heart, fetal, pool1	10046-101G1	66.43	55.96	4.72	3.49
hepatic mesenchymal tumor cell line:LI90	10778-110G4	41.96	81.76	0.00	4.63
hepatoblastoma cell line:HuH-6	10633-108I3	21.41	14.27	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	14.47	12.71	0.33	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	13.35	13.23	0.61	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	13.24	13.84	1.01	0.61
hepatoma cell line:Li-7	10484-107A7	10.68	9.45	0.11	1.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	17.09	8.24	1.91	0.10
hippocampus - adult, donor10196	10169-103B7	40.69	35.01	0.00	4.73
hippocampus, adult, donor10252	10153-102I9	54.29	76.33	1.84	3.67
hippocampus, adult, donor10258	10374-105G5	41.33	27.89	0.00	8.96
hippocampus, newborn, donor10223	10363-105F3	55.34	33.49	2.47	4.93
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	20.75	10.38	2.44	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	20.42	8.64	2.16	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	19.55	8.38	2.54	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	18.04	5.07	2.26	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	23.50	12.65	1.29	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	15.94	5.31	0.76	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	30.36	12.85	2.63	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	28.22	15.94	1.94	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	25.44	13.35	2.92	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	23.21	10.66	1.18	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	27.32	14.30	2.57	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	30.30	8.75	4.04	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	13.77	10.48	2.66	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	13.76	5.90	1.47	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	14.84	2.62	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	24.44	13.17	3.05	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	23.11	15.70	2.62	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	30.49	10.99	2.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	24.87	8.67	2.45	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	27.74	10.46	1.36	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	23.18	10.02	2.82	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	21.23	12.08	2.94	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	23.52	11.90	2.32	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.01	11.06	2.69	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	18.66	8.87	2.96	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	18.54	11.41	1.71	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	18.78	11.43	2.04	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	23.59	13.03	3.52	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	29.14	10.45	1.27	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	19.67	9.68	2.42	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	23.27	10.34	2.59	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	21.92	7.31	1.33	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	16.67	8.72	1.28	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	18.66	13.29	1.02	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	25.75	3.03	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	16.80	5.71	3.02	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	18.11	10.14	1.93	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	16.49	7.58	3.12	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	22.93	11.22	0.98	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	28.73	12.84	2.14	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	16.27	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	17.21	10.26	1.65	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	21.89	11.49	2.19	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	17.73	10.13	1.81	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	20.28	8.19	1.42	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	23.87	5.97	1.19	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	26.27	9.89	1.22	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	22.09	6.47	1.89	0.81
immature langerhans cells, donor1	11904-125F5	15.74	6.30	1.45	0.00
immature langerhans cells, donor2	11905-125F6	19.01	9.51	0.79	1.58
insula, adult, pool1	10039-101F3	84.32	51.20	2.74	6.06
keratoacanthoma cell line:HKA-1	10791-110H8	20.81	19.83	0.65	1.30
kidney, adult, pool1	10017-101C8	23.73	15.92	0.90	1.50
kidney, fetal, pool1	10045-101F9	57.58	35.08	1.70	2.62
large cell lung carcinoma cell line:IA-LM	10509-107D5	55.81	63.48	0.85	4.69
large cell lung carcinoma cell line:NCI-H460	10839-111E2	12.44	8.02	1.11	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	19.08	22.39	1.10	1.28
left atrium, adult, donor1	10079-102A7	29.42	30.51	0.54	1.63
left ventricle, adult, donor1	10078-102A6	34.89	33.88	0.51	1.01
leiomyoblastoma cell line:G-402	10721-110A1	45.69	69.50	0.55	3.28
leiomyoma cell line:10964C	10569-108B2	16.53	21.20	0.00	1.80
leiomyoma cell line:15242A	10570-108B3	22.28	43.48	1.63	1.63
leiomyoma cell line:15425	10571-108B4	22.34	25.98	0.49	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	12.70	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	13.59	16.73	1.05	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	15.47	5.90	0.94	0.47
liposarcoma cell line:KMLS-1	10782-110G8	29.06	37.33	0.94	1.41
liposarcoma cell line:SW 872	10726-110A6	41.79	54.46	0.73	3.53
liver, adult, pool1	10018-101C9	10.05	8.75	0.16	0.32
liver, fetal, pool1	10086-102B5	12.23	13.17	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	53.23	41.71	1.02	3.94
locus coeruleus, adult, donor10252	10165-103B3	43.00	45.21	1.11	4.43
locus coeruleus, adult, donor10258	10375-105G6	33.01	29.06	0.56	4.23
locus coeruleus, newborn, donor10223	10362-105F2	37.44	22.29	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	14.25	15.78	0.55	1.11
lung adenocarcinoma cell line:PC-14	10408-106B3	37.92	42.05	3.45	2.76
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	68.94	131.82	0.66	12.00
lung, adult, pool1	10019-101D1	33.90	27.64	0.35	2.13
lung, fetal, donor1	10068-101I5	68.21	46.24	0.86	5.99
lung, right lower lobe, adult, donor1	10075-102A3	34.82	25.20	0.92	1.37
lymph node, adult, donor1	10077-102A5	15.62	16.09	1.89	0.95
lymphangiectasia cell line:DS-1	10727-110A7	15.78	16.44	0.22	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	10.56	4.38	0.75	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.94	19.54	0.00	0.00
mature adipocyte, donor1	12231-129F8	60.83	41.29	1.78	4.00
mature adipocyte, donor2	12232-129F9	52.09	56.45	1.04	4.77
mature adipocyte, donor3	12233-129G1	43.38	42.20	0.47	3.79
mature adipocyte, donor4	12234-129G2	40.80	45.27	0.79	3.16
maxillary sinus tumor cell line:HSQ-89	10414-106B9	31.69	35.50	0.95	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	37.23	32.71	1.13	7.90
medial frontal gyrus, adult, donor10252	10150-102I6	53.88	61.79	0.74	5.70
medial frontal gyrus, adult, donor10258	10368-105F8	49.24	36.53	0.64	3.49
medial frontal gyrus, newborn, donor10223	10352-105E1	32.41	24.31	2.56	4.26
medial temporal gyrus - adult, donor10196	10183-103D3	64.29	70.37	1.18	3.71
medial temporal gyrus, adult, donor10252	10156-103A3	61.33	65.58	0.42	5.73
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	84.76	15.41	0.00	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	43.06	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	55.99	24.05	2.51	3.95
medulla oblongata - adult, donor10196	10174-103C3	37.64	24.66	0.65	5.84
medulla oblongata, adult, donor10252	10155-103A2	50.00	39.94	1.08	3.87
medulla oblongata, adult, pool1	10038-101F2	54.45	42.04	2.04	4.33
medulla oblongata, newborn, donor10223	10361-105F1	39.93	28.47	0.35	2.08
medulloblastoma cell line:D283 Med	10838-111E1	20.15	9.74	1.55	0.44
medulloblastoma cell line:ONS-76	10759-110E3	23.11	19.44	0.86	0.49
melanoma cell line:COLO 679	10514-107E1	26.02	8.19	1.01	0.86
melanoma cell line:G-361	10465-106H6	9.77	5.97	0.27	0.81
meningioma cell line:HKBMM	10691-109F7	22.43	41.43	0.18	1.99
merkel cell carcinoma cell line:MKL-1	10843-111E6	66.09	24.67	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	55.73	21.77	5.96	1.56
mesenchymal precursor cell - adipose, donor1	11747-123G1	21.48	28.23	0.61	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	19.81	18.91	0.18	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	14.08	12.01	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	13.06	12.92	0.42	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	14.25	16.75	0.39	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	26.37	11.11	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	9.44	8.92	0.34	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	14.84	12.77	0.12	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	19.76	20.69	0.93	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.29	15.39	0.68	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	23.47	20.49	1.00	1.56
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	3.95	3.62	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	17.71	18.68	0.28	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	21.29	17.45	0.35	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	20.82	32.87	0.20	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	28.76	22.29	0.72	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	11.07	12.83	0.62	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	14.59	20.52	0.00	1.37
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	23.08	27.27	0.00	2.52
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	20.77	21.07	0.60	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	13.39	18.29	0.44	0.61
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	20.99	19.14	0.00	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	30.05	39.49	0.57	3.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	48.84	52.63	3.79	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	22.83	23.29	0.91	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	27.37	15.86	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	24.34	24.08	0.79	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	22.49	20.33	1.23	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	20.71	16.24	0.94	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	22.00	18.95	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	26.33	16.11	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.93	12.97	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	25.67	17.02	1.15	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	26.77	18.29	0.45	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	22.11	21.63	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	30.07	35.93	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	22.15	16.78	1.01	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	31.11	14.33	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	22.34	17.18	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	27.34	2.73	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	23.06	16.24	0.97	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	23.28	14.55	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	36.78	16.53	1.07	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	33.53	16.36	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	30.71	22.93	0.00	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	18.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	27.82	20.86	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	23.84	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	18.97	16.01	0.59	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	9.75	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	54.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	27.87	17.73	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	19.31	16.21	0.34	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	23.64	8.60	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	7.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	17.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.15	10.59	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	8.74	12.71	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	15.92	9.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.47	9.35	0.62	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	14.70	8.02	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	20.11	17.74	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	25.68	10.27	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	25.47	16.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	11.88	14.35	0.00	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	11.22	14.58	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	15.27	10.81	0.64	2.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	17.73	9.27	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	17.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	20.27	12.67	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	14.57	9.10	0.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	18.08	4.52	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	20.59	18.94	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	23.41	16.07	0.79	1.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	15.58	12.01	0.00	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	22.41	11.20	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	37.14	48.74	0.00	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	34.26	26.22	1.18	3.54
mesothelioma cell line:ACC-MESO-4	10494-107B8	16.22	8.11	0.46	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	17.09	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	11.10	10.58	0.41	0.41
mesothelioma cell line:Mero-25	10850-111F4	5.22	4.31	0.45	0.45
mesothelioma cell line:Mero-41	10851-111F5	21.02	18.58	0.73	0.73
mesothelioma cell line:Mero-48a	10852-111F6	24.80	24.58	1.33	1.55
mesothelioma cell line:Mero-82	10853-111F7	27.59	25.23	0.53	1.84
mesothelioma cell line:Mero-83	10854-111F8	27.75	20.43	0.85	1.02
mesothelioma cell line:Mero-84	10855-111F9	25.28	17.44	0.51	1.26
mesothelioma cell line:Mero-95	10856-111G1	14.08	9.32	0.62	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	51.85	63.94	0.99	5.80
mesothelioma cell line:NCI-H226	10846-111E9	21.36	22.26	0.18	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	14.35	12.81	0.51	1.02
mesothelioma cell line:NCI-H28	10845-111E8	10.43	5.60	0.51	1.02
mesothelioma cell line:No36	10857-111G2	23.16	17.29	0.98	0.65
mesothelioma cell line:ONE58	10858-111G3	12.46	13.28	0.27	0.81
migratory langerhans cells, donor1	11901-125F2	2.49	0.58	0.77	0.00
migratory langerhans cells, donor2	11902-125F3	5.50	0.85	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	6.28	1.62	0.72	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	23.83	27.42	0.65	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	32.85	52.14	0.00	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	38.70	92.37	0.23	9.68
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	9.32	3.62	0.57	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	29.38	24.21	1.11	1.66
myeloma cell line:PCM6	10474-106I6	5.14	1.78	0.79	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	18.77	26.38	0.51	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	20.20	11.18	0.98	1.77
nasal epithelial cells, donor1, tech_rep1	12226-129F3	17.05	18.72	0.89	1.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	17.72	19.41	0.29	1.32
nasal epithelial cells, donor2	12227-129F4	17.11	17.11	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	75.46	48.77	3.22	4.60
neuroblastoma cell line:NB-1	10539-107G8	41.53	16.84	2.06	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	12.44	5.90	1.05	1.90
neuroblastoma cell line:NH-12	10555-107I6	17.89	6.89	3.91	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	23.96	14.95	0.95	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	32.78	25.66	1.43	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	23.75	16.50	5.64	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	13.99	9.54	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	38.86	65.21	0.27	4.26
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	59.19	35.35	2.20	1.35
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	29.62	15.21	0.00	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	16.03	17.63	0.00	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	17.61	28.12	0.79	0.53
nucleus accumbens, adult, pool1	10037-101F1	72.65	59.52	1.78	5.06
occipital cortex - adult, donor10196	10172-103C1	37.09	47.39	0.00	6.18
occipital cortex, adult, donor10252	10163-103B1	63.07	75.14	1.34	5.10
occipital cortex, newborn, donor10223	10355-105E4	70.61	32.39	2.91	2.18
occipital lobe, adult, donor1	10076-102A4	42.77	52.74	2.10	5.51
occipital lobe, fetal, donor1	10073-102A1	96.55	45.06	6.01	5.58
occipital pole, adult, pool1	10036-101E9	64.81	43.76	2.21	5.28
olfactory region, adult	10195-103E6	44.13	47.00	1.53	5.54
optic nerve, donor1	10277-104E7	50.03	30.02	0.00	8.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	22.21	12.87	0.80	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	20.61	17.59	0.27	1.24
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	16.42	16.59	0.85	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	46.55	53.13	0.69	4.62
osteoclastoma cell line:Hs 706.T	10704-109H2	34.69	31.45	0.00	2.06
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	64.47	51.39	0.93	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	378.10	219.06	10.18	15.69
ovary, adult, pool1	10020-101D2	36.34	21.31	1.66	1.57
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	10.82	12.10	0.18	1.10
pancreas, adult, donor1	10049-101G4	33.86	20.69	2.82	4.70
pancreatic carcinoma cell line:NOR-P1	10698-109G5	23.76	8.95	1.68	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	39.35	37.82	0.68	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	68.88	89.75	0.50	10.76
paracentral gyrus, adult, pool1	10035-101E8	62.69	47.87	2.47	4.48
parietal cortex, adult, donor10258	10373-105G4	64.59	44.77	2.94	10.28
parietal lobe - adult, donor10196	10171-103B9	35.74	28.21	0.94	6.58
parietal lobe, adult, donor10252	10157-103A4	54.73	66.41	0.57	3.42
parietal lobe, adult, pool1	10034-101E7	58.07	44.50	2.38	5.46
parietal lobe, fetal, donor1	10072-101I9	107.65	53.34	7.76	1.94
parietal lobe, newborn, donor10223	10356-105E5	54.21	26.17	1.87	3.36
parotid gland, adult	10199-103F1	24.05	18.50	0.00	1.23
penis, adult	10200-103F2	41.89	42.43	2.15	3.22
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	16.36	7.25	1.12	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	11.22	9.76	0.87	0.87
pineal gland - adult, donor10196	10179-103C8	45.80	39.99	0.00	5.16
pineal gland, adult, donor10252	10160-103A7	66.33	36.12	1.78	4.74
pineal gland, adult, donor10258	10377-105G8	43.90	26.34	2.51	4.39
pituitary gland - adult, donor10196	10180-103C9	35.41	27.32	2.02	3.04
pituitary gland, adult, donor10252	10162-103A9	75.57	45.34	1.56	1.04
pituitary gland, adult, donor10258	10378-105G9	50.22	22.13	3.40	2.55
placenta, adult, pool1	10021-101D3	36.34	33.97	0.86	2.04
plasma cell leukemia cell line:ARH-77	10840-111E3	6.09	4.37	0.66	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	24.90	21.48	0.62	0.31
pons, adult, pool1	10033-101E6	43.21	34.60	1.38	4.39
postcentral gyrus, adult, pool1	10032-101E5	62.07	50.74	1.83	5.06
promyelocytes/myelocytes PMC, donor1	12132-128D8	43.92	4.18	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	18.64	16.46	0.29	0.29
prostate cancer cell line:PC-3	10439-106E7	78.59	88.39	0.54	14.16
prostate, adult, pool1	10022-101D4	36.10	21.68	1.36	1.54
putamen, adult, donor10196	10176-103C5	69.40	84.98	2.36	5.19
putamen, adult, donor10252	10152-102I8	84.31	109.80	1.96	13.73
putamen, adult, donor10258, tech_rep1	10372-105G3	65.57	17.48	0.00	6.56
putamen, adult, donor10258, tech_rep2	10372-105G3	100.51	73.45	1.93	6.52
putamen, newborn, donor10223	10365-105F5	32.24	15.74	0.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	36.08	30.26	1.16	3.20
rectum, fetal, donor1	10067-101I4	73.72	80.68	4.17	6.95
renal cell carcinoma cell line:OS-RC-2	10411-106B6	27.98	26.92	0.21	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	7.87	3.73	0.00	0.41
retina, adult, pool1	10030-101E3	51.19	52.68	2.58	4.27
retinoblastoma cell line:Y79	10475-106I7	49.62	22.08	2.60	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	13.77	5.29	1.60	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	52.87	23.06	1.12	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	9.85	21.98	0.00	3.03
salivary acinar cells, donor1	11771-123I7	14.89	15.70	0.32	0.65
salivary acinar cells, donor2	11772-123I8	15.70	14.59	0.14	0.55
salivary acinar cells, donor3	11773-123I9	23.17	27.81	0.66	1.32
salivary gland, adult, pool1	10093-102C3	39.46	21.16	0.00	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	11.55	4.97	0.42	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	10.11	6.00	1.53	0.47
seminal vesicle, adult	10201-103F3	31.22	24.87	0.53	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	39.60	50.77	0.49	3.89
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	12.83	8.56	0.50	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	17.06	4.01	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	26.86	25.92	0.13	2.55
signet ring carcinoma cell line:Kato III	10436-106E4	21.11	18.24	0.22	0.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	8.26	9.42	0.00	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	36.18	88.67	0.00	12.77
skeletal muscle, adult, pool1	10023-101D5	41.62	43.42	1.44	4.08
skeletal muscle, fetal, donor1	10066-101I3	45.23	43.22	0.00	3.02
skin, adult, donor1	10074-102A2	27.14	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	33.46	45.45	1.26	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	34.02	16.01	1.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	40.98	22.69	2.21	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	10.22	4.82	0.77	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	17.14	10.88	0.66	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	40.37	28.47	3.86	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	32.47	11.77	1.53	0.87
small intestine, adult, pool1	10024-101D6	26.28	25.56	0.12	2.39
small intestine, fetal, donor1	10064-101I1	30.22	35.87	0.74	3.19
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	8.21	7.69	1.54	0.51
smooth muscle, adult, pool1	10048-101G3	35.15	32.05	0.26	1.55
somatostatinoma cell line:QGP-1	10781-110G7	14.21	8.84	0.80	1.07
spinal cord - adult, donor10196	10181-103D1	43.59	41.75	0.46	5.51
spinal cord, adult, donor10252	10159-103A6	42.19	42.19	1.18	5.91
spinal cord, adult, donor10258	10369-105F9	20.06	19.37	0.69	5.53
spinal cord, fetal, donor1	10056-101H2	45.13	51.84	0.61	1.83
spinal cord, newborn, donor10223	10359-105E8	47.30	27.55	0.92	2.76
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	50.33	78.86	0.75	8.66
spleen, adult, pool1	10025-101D7	28.30	20.48	1.21	1.65
spleen, fetal, pool1	10044-101F8	52.84	34.09	1.35	1.43
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	7.25	3.21	1.55	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	37.41	51.08	0.19	2.28
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	31.10	36.34	2.10	2.80
squamous cell carcinoma cell line:T3M-5	10616-108G4	48.87	61.38	0.39	2.35
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	31.18	24.31	0.90	2.03
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	28.80	8.90	1.69	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	33.85	23.27	4.65	1.69
stomach, fetal, donor1	10062-101H8	41.65	59.81	0.00	3.20
submaxillary gland, adult	10202-103F4	37.03	18.23	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	43.83	42.79	0.62	5.40
substantia nigra, adult, donor10258	10371-105G2	40.86	25.35	0.00	6.21
substantia nigra, newborn, donor10223	10358-105E7	51.58	24.73	0.00	4.95
synovial sarcoma cell line:HS-SY-II	10441-106E9	21.78	7.80	2.29	0.69
temporal lobe, adult, pool1	10031-101E4	72.73	51.03	2.97	6.10
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	81.20	39.17	4.27	4.27
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	66.37	23.30	7.91	1.32
tenocyte, donor1	11763-123H8	32.47	26.53	0.00	1.75
tenocyte, donor2	11765-123I1	21.75	27.85	0.00	0.76
tenocyte, donor3	11768-123I4	22.24	37.07	1.11	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	28.38	12.24	3.23	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	14.64	7.86	2.47	0.46
teratocarcinoma cell line:PA-1	10807-111A6	21.54	12.86	3.41	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	26.28	19.55	2.79	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	24.96	6.05	1.89	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	17.23	18.54	1.09	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	43.32	13.68	1.63	1.30
testis, adult, pool1	10026-101D8	38.76	28.24	1.93	1.50
testis, adult, pool2	10096-102C6	50.07	31.12	7.22	1.35
thalamus - adult, donor10196	10168-103B6	58.51	30.91	0.00	8.83
thalamus, adult, donor10252	10154-103A1	58.45	68.14	1.09	6.72
thalamus, adult, donor10258, tech_rep1	10370-105G1	81.60	23.09	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	40.84	33.93	0.99	4.12
thalamus, newborn, donor10223	10366-105F6	31.64	22.44	0.00	2.88
throat, adult	10209-103G2	35.70	33.46	2.00	3.25
throat, fetal, donor1	10061-101H7	46.62	39.92	1.22	5.18
thymic carcinoma cell line:Ty-82	10803-111A2	38.55	22.85	1.39	1.19
thymus, adult, pool1	10027-101D9	28.04	12.63	3.38	0.30
thymus, fetal, pool1	10043-101F7	39.48	16.73	3.84	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	25.79	13.03	0.80	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	71.24	78.93	1.96	4.75
thyroid, adult, pool1	10028-101E1	43.11	25.01	1.49	2.15
thyroid, fetal, donor1	10060-101H6	46.67	45.61	0.26	2.64
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	33.88	3.08	0.00
tongue, adult	10203-103F5	23.03	30.47	0.70	1.63
tongue, fetal, donor1	10059-101H5	33.50	51.63	0.00	5.12
tonsil, adult, pool1	10047-101G2	37.47	25.04	0.90	1.40
trachea, adult, pool1	10029-101E2	23.48	18.81	0.74	0.90
trachea, fetal, donor1	10058-101H4	36.55	38.08	0.77	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	26.92	29.05	1.42	2.83
transitional-cell carcinoma cell line:5637	10418-106C4	46.30	39.31	1.52	3.65
transitional-cell carcinoma cell line:JMSU1	10492-107B6	17.86	13.01	1.25	0.63
tridermal teratoma cell line:HGRT	10694-109G1	22.83	20.93	1.90	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	28.36	60.10	0.42	6.09
umbilical cord, fetal, donor1	10057-101H3	41.73	50.08	4.17	4.17
uterus, adult, pool1	10100-102D1	72.69	58.53	1.54	4.61
uterus, fetal, donor1	10055-101H1	53.75	77.30	1.02	2.05
vagina, adult	10204-103F6	58.16	40.06	2.58	1.94
vein, adult	10191-103E2	33.32	27.84	0.88	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	10.95	7.48	0.27	0.00